-
Product Name
TUSC2 antibody
- Documents
-
Description
TUSC2 Rabbit Polyclonal antibody. Positive IHC detected in human lung cancer tissue, human colon cancer tissue. Positive IF detected in A549 cells. Positive WB detected in human heart tissue, mouse pancreas tissue. Observed molecular weight by Western-blot: 10-12kd
-
Tested applications
ELISA, WB, IHC, IF
-
Species reactivity
Human,Mouse,Rat; other species not tested.
-
Alternative names
C3orf11 antibody; Fus 1 protein antibody; FUS1 antibody; Fusion 1 protein antibody; LGCC antibody; PAP antibody; PDAP2 antibody; PDGFA assOCiated protein 2 antibody; tumor suppressor candidate 2 antibody; TUSC2 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of TUSC2 recombinant protein (Accession Number: NM_007275). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IHC: 1:20-1:200
IF: 1:20-1:200
-
Validations
human heart tissue were subjected to SDS PAGE followed by western blot with Catalog No:116495(TUSC2 antibody) at dilution of 1:300
Immunohistochemistry of paraffin-embedded human colon cancer tissue slide using Catalog No:116495(TUSC2 Antibody) at dilution of 1:50 (under 40x lens)
Immunohistochemistry of paraffin-embedded human lung cancer tissue slide using Catalog No:116495(TUSC2 Antibody) at dilution of 1:50 (under 40x lens)
Immunofluorescent analysis of A549 cells using Catalog No:116495(TUSC2 Antibody) at dilution of 1:50 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
-
Background
FUS1 (or TUSC2) gene is a highly conserved lung cancer candidate gene, which was identified in the 120 kb 3p21.3 critical region contained in nested lung and breast cancer homozygous deletions. Overexpression of FUS1 gene leads to G1 arrest and growth inhibition of lung cancer cells (PMID: 11593436). The encoded Fusion-1 protein was down-regulated, mutated or lost in the majority of inflammatory thoracic malignancies. It has been evidenced that Fusion-1 establishes its immune- and tumour-suppressive activities via regulation of mitochondrial homeostasis (PMID: 22513871). In addition, myristoylation is found to be required for Fusion-1-mediated tumor-suppressing activity and suggest a novel mechanism for the inactivation of tumor suppressors in lung cancer and a role for deficient posttranslational modification in tumor suppressor-gene-mediated carcinogenesis (PMID: 15126327).
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"